Aptose Biosciences Inc. (APTO)

Aptose Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12	20	54	120	389	315
Market Cap Growth	-56.17%	-62.91%	-55.42%	-69.15%	23.71%	498.92%
Enterprise Value	4	12	8	42	268	219
PE Ratio	-	-0.39	-1.28	-1.84	-7.05	-11.97
PB Ratio	87.24	-6.84	1.42	1.62	3.27	3.35
P/FCF Ratio	-0.58	-0.44	-1.65	-2.76	-11.46	-14.52
P/OCF Ratio	-0.58	-0.45	-1.66	-2.77	-11.48	-14.59
EV/EBITDA Ratio	-0.38	-0.23	-0.19	-0.64	-4.90	-8.52
EV/EBIT Ratio	-0.37	-0.23	-0.19	-0.64	-4.85	-8.32
EV/FCF Ratio	-0.39	-0.26	-0.24	-0.95	-7.89	-10.09
Debt / Equity Ratio	6.71	-0.35	0.03	0.01	0.01	0.02
Debt / EBITDA Ratio	-0.02	-0.02	-0.03	-0.01	-0.02	-0.06
Debt / FCF Ratio	-0.02	-0.02	-0.04	-0.01	-0.03	-0.07
Quick Ratio	0.77	0.61	3.82	9.68	17.97	17.62
Current Ratio	0.97	0.78	4.03	10.00	18.36	17.83
Return on Equity (ROE)	-1003.70%	-458.70%	-81.50%	-70.60%	-53.30%	-61.60%
Return on Assets (ROA)	-257.60%	-205.30%	-68.10%	-65.20%	-50.30%	-55.10%
Return on Capital (ROIC)	-4547.35%	2776.03%	-109.11%	-87.48%	-46.48%	-28.13%
Earnings Yield	-394.66%	-257.91%	-78.13%	-54.43%	-14.19%	-8.35%
FCF Yield	-377.24%	-224.72%	-60.42%	-36.24%	-8.73%	-6.88%
Buyback Yield / Dilution	-112.82%	-9.82%	-3.57%	-8.86%	-63.15%	-50.22%
Total Shareholder Return	-112.82%	-9.82%	-3.57%	-8.86%	-63.15%	-50.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).